Vol 19, No 3 (2014)
- Year: 2014
- Articles: 11
- URL: https://rjonco.com/1028-9984/issue/view/2378
Articles
PREOPERATIVE CORRECTION OF WATER-ELECTROLYTE DISTURBANCES IN PATIENTS WITH ACUTE INTESTINAL OBSTRUCTION CAUSED BY COLON CANCER
Abstract
MODIFICATION OF PANCREATICOBILIARY TRACT RECONSTRUCTION AFTER PANCREADUODENECTOMY IN CHILDREN WITH PANCREATIC TUMOURS
Abstract
THE INITIAL RESULTS OF REMOTE MAMMOGRAPHY BREAST CANCER SCREENING
Abstract
ALGORITHM OF TREATMENT APPROACHES IN MEDIASTINAL NON-CHROMAFFIN PARAGANGLIOMAS
Abstract
COMPARISON OF EFFICACY AND TOLERANCE OF THE INTRAPERITONEAL CELL-BASED AND IL-2 IMMUNOTHERAPY OF PATIENTS WITH CHEMOTHERAPY-RESISTANT GASTRIC CANCER AND MALIGNANT ASCITES
Abstract
SIDE EFFECTS OF TWO REGIMENS OF TRIPLE-COMPONENT CHEMOTHERAPY (CAPECITABINE, OXALIPLATIN AND IRINOTECAN) AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
Abstract
CLINICAL CASES OF SUCCESSFUL TREATMENT OF PATIENTS WITH METASTATIC PLEURAL MESOTHELIOMA
Abstract
PREDICTION OF BREAST CANCER POSSIBILITY IN THE GENERAL HEALTH NETWORK
Abstract
CURRENT CRITERIA OF RADIAL DIAGNOSTICS TO ASSESS THE EFFECTIVENESS OF SPECIFIC CANCER TREATMENT
Abstract
Evaluation of tumor treatment response plays an important role in oncology. There were no precise methods for pre-operative assessment of tumor size until the wide introduction of CT and MRI. WHO criteria were introduced in 1979 were the first, but they had considerable limitations. It was the reason for creation of the relevant RECIST 1.0 and 1.1. With invention of new chemotherapy protocols approaches to treatment response assessment were changed. Therefore, new criteria of response to therapyf or some specific histological types of malignant tumors were developed. During the last few years, a necessity for developing specific treatment response criteria using PET/CT emerged; PERCIST 1.0 criteria are a useful tool for evaluation of tumor response by PET/CT. Wide usage of PERCIST 1.0 allows improved assessment of therapy response in general.